Option Care Health (NASDAQ:OPCH) Upgraded by Wall Street Zen to Buy Rating

Option Care Health (NASDAQ:OPCH) was upgraded by equities researchers at Wall Street Zen from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Saturday.

OPCH has been the subject of several other reports. Barrington Research reaffirmed an “outperform” rating and set a $38.00 price target on shares of Option Care Health in a research note on Friday, October 31st. Cowen started coverage on shares of Option Care Health in a research report on Thursday, October 2nd. They issued a “hold” rating on the stock. Citizens Jmp decreased their target price on shares of Option Care Health from $38.00 to $36.00 and set a “market outperform” rating for the company in a research report on Friday, October 31st. Citigroup reiterated an “outperform” rating on shares of Option Care Health in a research note on Friday, October 31st. Finally, JMP Securities set a $36.00 price target on shares of Option Care Health in a research report on Friday, October 31st. Nine research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat, Option Care Health presently has a consensus rating of “Moderate Buy” and a consensus price target of $35.67.

Option Care Health Price Performance

OPCH stock opened at $29.89 on Friday. The stock has a 50-day moving average price of $28.25 and a two-hundred day moving average price of $29.35. Option Care Health has a 1 year low of $22.29 and a 1 year high of $35.53. The stock has a market cap of $4.74 billion, a PE ratio of 23.72, a price-to-earnings-growth ratio of 2.11 and a beta of 0.80. The company has a current ratio of 1.56, a quick ratio of 1.05 and a debt-to-equity ratio of 0.85.

Insider Transactions at Option Care Health

In other news, Director Norman L. Wright bought 3,411 shares of the business’s stock in a transaction that occurred on Tuesday, September 9th. The stock was acquired at an average cost of $29.31 per share, for a total transaction of $99,976.41. Following the purchase, the director owned 15,501 shares of the company’s stock, valued at approximately $454,334.31. This trade represents a 28.21% increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Harry M. Jansen Kraemer, Jr. purchased 38,000 shares of Option Care Health stock in a transaction that occurred on Monday, November 3rd. The shares were acquired at an average price of $25.98 per share, with a total value of $987,240.00. Following the acquisition, the director directly owned 413,390 shares of the company’s stock, valued at $10,739,872.20. This trade represents a 10.12% increase in their position. The SEC filing for this purchase provides additional information. Company insiders own 0.64% of the company’s stock.

Hedge Funds Weigh In On Option Care Health

Several institutional investors and hedge funds have recently modified their holdings of OPCH. USA Financial Formulas bought a new position in shares of Option Care Health in the second quarter valued at about $26,000. Cornerstone Planning Group LLC grew its stake in Option Care Health by 7,621.4% in the 3rd quarter. Cornerstone Planning Group LLC now owns 1,081 shares of the company’s stock valued at $30,000 after buying an additional 1,067 shares during the last quarter. Northwestern Mutual Wealth Management Co. grew its stake in Option Care Health by 1,492.9% in the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 892 shares of the company’s stock valued at $31,000 after buying an additional 836 shares during the last quarter. Advisory Services Network LLC bought a new position in Option Care Health in the 3rd quarter valued at about $35,000. Finally, McIlrath & Eck LLC acquired a new stake in Option Care Health during the second quarter worth approximately $37,000. 98.05% of the stock is currently owned by institutional investors and hedge funds.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.